Schering-Plough Corp. - Specimen Stock Certificate

Specimen Stock printed by Security-Columbian Banknote Company. Incorporated in 1970. Schering-Plough Corporation was an American pharmaceutical firm. Initially, it served as the U.S. subsidiary of the German company Schering AG, established in 1851 by Ernst Christian Friedrich Schering. Following nationalization, it transitioned into an independent entity. In 1971, Schering Corporation merged with Plough, Inc., which was founded by Memphis entrepreneur Abe Plough in 1908, resulting in the formation of Schering-Plough.

On November 4, 2009, Merck & Co. merged with Schering-Plough, with the newly formed company adopting the name Merck & Co. Schering-Plough produced various pharmaceutical products, among which the most recognized were the allergy medications Claritin and Clarinex, the anti-cholesterol drug Vytorin, and the brain tumor treatment Temodar. These products are now marketed by Merck & Co. Additionally, Schering-Plough owned and managed the prominent foot care brand Dr. Scholl's and the skincare line Coppertone, both of which became part of the new entity. As of June 2005, Schering-Plough held a 1.4% market share in the U.S., ranking seventeenth among the top twenty pharmaceutical companies by sales, as reported by IMS Health. Schering-Plough was a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), a membership that continues under the new Merck & Co.